Abstract

BackgroundAcetazolamide is recommended for the reduction of cerebrospinal fluid production in canine internal hydrocephalus. The efficacy of the drug in terms of alleviation of the clinical symptoms and the restoration of normal ventricular volume has not been documented. We hypothesize that acetazolamide inadequately improve clinical signs and has no effect on the ventricular volume. Six dogs with internal hydrocephalus underwent neurological examination and were examined by magnetic resonance imaging, on the day of the diagnosis, after treatment with acetazolamide directly before surgery, and 6 weeks after implantation of a vetriculo-peritoneal shunt due to lack of improvement after medical therapy with 10 mg/kg acetazolamide three times daily (TID). The ventricular volume in relation to the total brain volume was determined on each occasion. The changes in relative ventricular volume and of the neurological status were assessed and compared.ResultsMcNemar’s test revealed no significant differences in clinical symptoms before and after medical treatment (P > 0.05). However, clinical symptoms changed significantly after surgical treatment (P = 0.001). The ventricle-brain ratio was not significantly changed after therapy with acetazolamide (P > 0.05); however, after subsequent shunt implantation, it was significantly reduced (P = 0.001).ConclusionAcetazolamide (10 mg/kg TID) showed no effects on clinical signs or ventricular volume in dogs with internal hydrocephalus. After subsequent ventriculo-peritoneal shunting, the dogs had a significantly reduced cerebral ventricular volume and five out of six dogs had no abnormal findings in neurological examination.

Highlights

  • Acetazolamide is recommended for the reduction of cerebrospinal fluid production in canine internal hydrocephalus

  • A mismatch between production and absorption leads to the accumulation of cerebrospinal fluid (CSF), increase of intraventricular pressure, and dilation of the ventricular system in affected animals

  • To objectively assess the efficacy of acetazolamide, we compared the development of clinical signs and ventricular volume before and after treatment with acetazolamide and after ventriculo-peritoneal shunting

Read more

Summary

Introduction

Acetazolamide is recommended for the reduction of cerebrospinal fluid production in canine internal hydrocephalus. Six dogs with internal hydrocephalus underwent neurological examination and were examined by magnetic resonance imaging, on the day of the diagnosis, after treatment with acetazolamide directly before surgery, and 6 weeks after implantation of a vetriculo-peritoneal shunt due to lack of improvement after medical therapy with 10 mg/kg acetazolamide three times daily (TID). A mismatch between production and absorption leads to the accumulation of cerebrospinal fluid (CSF), increase of intraventricular pressure, and dilation of the ventricular system in affected animals. Medical therapy for the lowering of high ventricular pressure which aims to reduce CSF production through the use of glucocorticoids and diuretics has been proposed as a reasonable treatment option in hydrocephalic dogs [2,3,4]. To objectively assess the efficacy of acetazolamide, we compared the development of clinical signs and ventricular volume before and after treatment with acetazolamide and after ventriculo-peritoneal shunting The carbonic anhydrase inhibitor acetazolamide has been proposed for medical treatment by some authors [2,3,4].

Methods
Results
Discussion
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.